June 27, 2022
Loading...
You are here:  Home  >  'Amgen'  -  Page 41
Latest

Europeans recommend approval of Amgen’s biosimilar of AbbVie’s Humira

By   /  Friday, January 27th, 2017  /  Health Care & Life Science, Latest news, Technology  /  Comments Off on Europeans recommend approval of Amgen’s biosimilar of AbbVie’s Humira

The European Medicines Agency recommended the approval of the ABP 501, a biosimilar of AbbVie’s Humira (adalimumab), for treatment of inflammatory diseases, Thousand Oaks-based biotech company Amgen announced on Jan. 27. The EMA recommended ABP 501’s use for moderate-to-severe rheumatoid arthritis, psoriatic arthritis, severe ankylosing spondylitis, severe axial spondyloarthritis without radiographic evidence of AS, moderate-to-severe Read More →

Latest

Patent ruling in favor of Amgen has shares skyrocketing

By   /  Friday, January 13th, 2017  /  Health Care & Life Science, Latest news, Tri-County Public Companies  /  Comments Off on Patent ruling in favor of Amgen has shares skyrocketing

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Amgen updates agreement with DaVita for dialysis treatment

By   /  Monday, January 9th, 2017  /  Health Care & Life Science, Latest news, Tri-County Public Companies  /  Comments Off on Amgen updates agreement with DaVita for dialysis treatment

Thousand Oaks biotech company Amgen entered into a six-year supply agreement with DaVita for dialysis treatments, the company announced on Jan. 9. Under the terms of the new agreement, Amgen will supply DaVita with Epogen and Aranesp for agents to stimulate red blood cells in dialysis treatment in the United States and Puerto Rico. The Read More →

Latest

Amgen partners with Immatics Biotechnologies to develop cancer drugs

By   /  Monday, January 9th, 2017  /  Health Care & Life Science, Latest news, Tri-County Public Companies  /  Comments Off on Amgen partners with Immatics Biotechnologies to develop cancer drugs

Thousand Oaks biotech company Amgen formed a potential $500 million partnership with Immatics Biotechnologies GmbH to research and develop next-generation, T-cell engaging bispecific immunotherapies targeting multiple cancers, the company announced on Jan. 9. Under the terms of the agreement, Immatics will receive $30 million upfront and can receive more than $500 million in development, regulatory Read More →

Latest

Amgen shares climb after judge upholds Repatha patents

By   /  Friday, January 6th, 2017  /  Health Care & Life Science, Latest news, Law & Goverment  /  Comments Off on Amgen shares climb after judge upholds Repatha patents

A ruling in a patent law case regarding a new anti-cholesterol drug involving Thousand Oaks biotech giant Amgen has skyrocketed Amgen shares. Amgen filed a patent infringement lawsuit against Sanofi and Regeneron in the U.S. District Court of Delaware in October 2014 to block the development and sale of the drug Praluent, which was developed Read More →

Latest

Corporate tax cut could fuel biotech mergers, acquisitions

By   /  Friday, January 6th, 2017  /  East Ventura County, Health Care & Life Science, left, Technology, Tri-County Economy  /  Comments Off on Corporate tax cut could fuel biotech mergers, acquisitions

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Legislators should help manufacturing rebound

By   /  Friday, December 23rd, 2016  /  Editorials, Latest news, Opinion  /  Comments Off on Legislators should help manufacturing rebound

While the South Coast is reveling in its waterfront makeover, tri-county tourism is getting stronger and economists are heralding a boom in craft spirits, the manufacturing core of the region is looking more and more hollowed-out. Large sections of Simi Valley and west Ventura County and North Santa Barbara County are losing head-of-household jobs. San Read More →